Evidence map›Paper›PMID 35281013›Full record

ArticleFrontiers in immunology2022

Case Report: Rotavirus Vaccination and Severe Combined Immunodeficiency in Japan.

Kay Tanita, Yoshiki Kawamura, Hiroki Miura, Noriko Mitsuiki, Takahiro Tomoda, Kento Inoue, Akihiro Iguchi, Masafumi Yamada, Taro Yoshida, Hideki Muramatsu and 10 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 1 country.

Kay TanitaDepartment of Pediatrics and Developmental Biology, Graduate School of Medical Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Yoshiki KawamuraDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.
Hiroki MiuraDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.
Noriko MitsuikiDepartment of Pediatrics and Developmental Biology, Graduate School of Medical Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Takahiro TomodaDepartment of Pediatrics and Developmental Biology, Graduate School of Medical Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Kento InoueDepartment of Pediatrics and Developmental Biology, Graduate School of Medical Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Akihiro IguchiDepartment of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Masafumi YamadaDepartment of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Taro YoshidaDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hideki MuramatsuDepartment of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Norimasa TadaDepartment of Pediatrics, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Toshihiro MatsuiChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Motohiro KatoChildren's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Katsuhide EguchiDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Masataka IshimuraDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Shouichi OhgaDepartment of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kohsuke ImaiDepartment of Community Pediatrics, Perinatal and Maternal Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Tomohiro MorioDepartment of Pediatrics and Developmental Biology, Graduate School of Medical Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Tetsushi YoshikawaDepartment of Pediatrics, Fujita Health University School of Medicine, Toyoake, Japan.
Hirokazu KaneganeDepartment of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
Tokyo Medical and Dental University · JPFujita Health University · JPKyushu University · JPNational Center For Child Health and Development · JPNagoya University · JPThe University of Tokyo · JPHokkaido University · JPTsuchiura Kyodo General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe combined immunodeficiency (SCID) is an inborn error of immunity that occurs in approximately 1 in 50,000 births, mainly due to impaired lymphocyte differentiation. Without curative treatment, such as hematopoietic cell transplantation (HCT) or gene therapy, severe infection in the first year of life could make this condition fatal. The results of HCT are poor when patients have active infections, thus requiring early diagnosis before onset of infection. In five cases of SCID diagnosed in Japan, the oral rotavirus vaccine had been administered before diagnosis. In this study, we demonstrated that the rotavirus from their stools was a vaccine-derived strain. In some cases, severe gastroenteritis triggered the diagnosis of SCID. However, newborn screening for SCID is available before the first rotavirus vaccination using assays for the detection of T-cell receptor excision circles (TRECs). Therefore, to improve the prognosis of patients with SCID in Japan, we should establish a screening system of TRECs for newborns throughout Japan.

Indexed as

RotavirusSevere Combined ImmunodeficiencyDNAHumansInfant, NewbornJapanNeonatal ScreeningVaccinationDNAhematopoietic cell transplantationrotavirussevere combined immunodeficiencyT-cell receptor excision circles (TREC)vaccination

Identifiers

PMID35281013
PMCPMC8905240
OpenAlexW4214490989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.